Toronto - Delayed Quote CAD

Delta 9 Cannabis Inc. (DN.TO)

0.0250 +0.0050 (+25.00%)
At close: April 26 at 1:04 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
71,065.3370
71,065.3370
63,228.2710
62,291.4360
52,047.0530
Cost of Revenue
56,620.7560
56,620.7560
52,349.5820
44,972.1600
34,048.7870
Gross Profit
14,444.5810
14,444.5810
10,878.6890
17,319.2760
17,998.2660
Operating Expense
27,937.7450
27,937.7450
31,136.9500
24,958.5630
20,765.9180
Operating Income
-13,493.1640
-13,493.1640
-20,258.2610
-7,639.2870
-2,767.6520
Net Non Operating Interest Income Expense
-6,784.6620
-6,784.6620
-6,979.3580
-4,268.7850
-3,154.2140
Other Income Expense
3,642.1950
3,642.1950
-599.3310
364.8300
837.6810
Pretax Income
-16,635.6310
-16,635.6310
-27,836.9500
-11,543.2420
-5,084.1850
Tax Provision
--
--
--
-401.0150
401.0150
Net Income Common Stockholders
-17,515.3390
-17,515.3390
-27,200.5570
-11,177.4870
-6,417.5250
Diluted NI Available to Com Stockholders
-17,515.3390
-17,515.3390
-27,200.5570
-11,177.4870
-6,417.5250
Basic EPS
-0.15
-0.10
-0.22
-0.11
-0.07
Diluted EPS
-0.15
-0.10
-0.22
-0.11
-0.07
Basic Average Shares
164,144.8000
178,944.1500
126,067.0440
103,343.8760
89,425.9960
Diluted Average Shares
164,144.8000
178,944.1500
126,067.0440
103,343.8760
89,425.9960
Total Operating Income as Reported
-13,493.1640
-13,493.1640
-20,258.2610
-7,639.2870
-2,767.6520
Total Expenses
84,558.5010
84,558.5010
83,486.5320
69,930.7230
54,814.7050
Net Income from Continuing & Discontinued Operation
-17,515.3390
-17,515.3390
-27,200.5570
-11,177.4870
-6,417.5250
Normalized Income
-17,437.3390
-17,437.3390
-26,288.5610
-11,177.4870
-6,559.5718
Interest Income
21.2540
21.2540
116.7100
31.1200
44.1580
Interest Expense
6,805.9160
6,805.9160
6,601.6020
3,898.9100
3,198.3720
Net Interest Income
-6,784.6620
-6,784.6620
-6,979.3580
-4,268.7850
-3,154.2140
EBIT
-9,829.7150
-9,829.7150
-21,235.3480
-7,644.3320
-1,885.8130
EBITDA
-1,042.3720
-1,042.3720
-13,268.9400
-1,169.2510
3,429.1130
Reconciled Cost of Revenue
56,450.5370
56,450.5370
52,229.3780
44,825.3720
32,334.0620
Reconciled Depreciation
8,787.3430
8,787.3430
7,966.4080
6,475.0810
5,314.9260
Net Income from Continuing Operation Net Minority Interest
-17,515.3390
-17,515.3390
-27,200.5570
-11,177.4870
-6,417.5250
Total Unusual Items Excluding Goodwill
-78.0000
-78.0000
-911.9960
--
193.2610
Total Unusual Items
-78.0000
-78.0000
-911.9960
--
193.2610
Normalized EBITDA
-964.3720
-964.3720
-12,356.9440
-1,169.2510
3,235.8520
Tax Rate for Calcs
--
--
--
0.0000
0.0003
Tax Effect of Unusual Items
--
--
--
--
51.2142
12/31/2020 - 11/6/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XLY.TO Auxly Cannabis Group Inc.
0.0550
+10.00%
 
NDVA.V Indiva Limited
0.0650
-13.33%
 
DB.V Decibel Cannabis Company Inc.
0.1300
0.00%
 
XTRX.CN Adastra Holdings Ltd.
0.2150
+4.88%
 
CRON.TO Cronos Group Inc.
3.5300
+2.62%
 
AVCN.TO Avicanna Inc.
0.3600
+5.88%
 
LABS.TO MediPharm Labs Corp.
0.0800
0.00%
 
PHRX.CN Pharmadrug Inc.
0.0300
-14.29%
 
FFNT.CN 4Front Ventures Corp.
0.1300
+4.00%
 
LOVE.V Cannara Biotech Inc.
0.8400
-1.18%